Vanda Pharmaceuticals to Participate in the Canaccord Genuity Rare Disease, Biopharma One-on-One Day

WASHINGTON, Jan. 29, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that members of its management team will participate in the Canaccord Genuity Rare Disease, Biopharma One-on-One Day on Tuesday, February 3, 2015 in New York, NY.

For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Senior Vice President and Chief Financial Officer

Vanda Pharmaceuticals Inc.

SOURCE Vanda Pharmaceuticals Inc.

more press release views with